Skip to content

Study · Other design · n = 52 · 2020

2 results

Functional Connectomic Approach to Studying Selank and Semax Effects.

Panikratova YR, Lebedeva IS, Sokolov OY, Rumshiskaya AD, Kupriyanov DA, Kost NV, Myasoedov NF

Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections1 Jan 2020Cited by 2 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanOther designMechanism

    In healthy participants, Selank and Semax had general and specific effects on functional connectivity between the right amygdala and the right temporal cortex; the abstract gives no direction for Selank.

    In plain wordsIn healthy adults, Selank changed how the right amygdala communicates with the right temporal cortex, as seen on brain scans.

    Peptide
    Selank
    Outcome
    Direction not reportedResting-state functional connectivity of the right amygdala with the right temporal cortex
    Study

    n = 52

    Comparator
    Placebo
    Outcome group
    Brain and neuronal activity · Nervous system and cognition
    Studied dose
    Dose not stated · injectionAs given in this study (human).

    Source sentences

    Summary
    Between-group alongwith between-condition differences were revealed in FC between the right amygdala and a region in fusiform, inferior and middle temporal as well as parahippocampal gyri in the right hemisphere.
    3 context sentences
    Summary · context
    Post hoc analysis allowed us to define both general and specific effects of Selank and Semax on FC between the right amygdala and the right temporal cortex for the first time.
    Summary · context
    The present study was aimed at the assessment of effects of anxiolytic Selank and nootropic Semax on the whole-brain resting-state functional connectivity (FC) of each of the predefined regions of interest (ROIs) in 52 healthy participants.
    Summary · context
    Resting-state fMRI was carried out three times, namely before, after 5 and 20 min of the injection of either Semax, or Selank, or placebo.
  2. 02HumanOther designMechanism

    In 52 healthy participants, Semax injection altered resting-state functional connectivity between the right amygdala and the right temporal cortex, compared with placebo and across time points.

    In plain wordsIn healthy adults, Semax injection changed how the right amygdala connects with the right temporal cortex in brain scans, compared with placebo.

    Peptide
    Semax
    Outcome
    Direction not reportedResting-state functional connectivity of the right amygdala
    Study

    n = 52

    Comparator
    Placebo
    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    Dose not stated · injectionAs given in this study (human).

    Source sentences

    Summary
    Between-group alongwith between-condition differences were revealed in FC between the right amygdala and a region in fusiform, inferior and middle temporal as well as parahippocampal gyri in the right hemisphere.
    3 context sentences
    Summary · context
    Post hoc analysis allowed us to define both general and specific effects of Selank and Semax on FC between the right amygdala and the right temporal cortex for the first time.
    Summary · context
    The present study was aimed at the assessment of effects of anxiolytic Selank and nootropic Semax on the whole-brain resting-state functional connectivity (FC) of each of the predefined regions of interest (ROIs) in 52 healthy participants.
    Summary · context
    Resting-state fMRI was carried out three times, namely before, after 5 and 20 min of the injection of either Semax, or Selank, or placebo.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Versions 3 to 38Current

    28 Oct 2026, 02:04 UTC

    The same notice was added 36 times, first on 9 Oct 2026, 19:08 UTC. The status did not change between them.

    Study results updated

  2. Version 2

    9 Oct 2026, 03:04 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.